TITLE:
Evaluation of the Effect on Glucose Control and Safety of AC2993 in Patients With Type 2 Diabetes Treated With Metformin, Sulfonylurea, or Metformin and Sulfonylurea Combination

CONDITION:
Diabetes Mellitus, Type 2

INTERVENTION:
AC2993

SUMMARY:

      This multi-center, open-label study is designed to examine the effects on long-term glucose
      control and safety of AC2993 in patients with type 2 diabetes treated with metformin,
      sulfonylurea, or metformin and sulfonylurea combination.
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: All
Age: 20 Years to 75 Years
Criteria:

        Inclusion Criteria:

          -  Subjects with type 2 diabetes

          -  Treated for at least 3 months prior to screening either with metformin, sulfonylurea,
             or metformin and sulfonylurea combination

          -  BMI 25-45 kg/m^2

          -  HbA1c between 7.5 % and 12.0 %, inclusive

        Exclusion Criteria:

          -  Treated with other oral anti-diabetic agents other than metformin and sulfonylureas
             within 3 months of screening

          -  Patients previously treated with AC2993

          -  Patients presently treated with insulin
      
